Clinical trial NCT05736679: EaveTubes for Vector Control
Official title: EaveTubes for Control of Vector Borne Diseases in Côte d'Ivoire
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Malaria
Keywords: EaveTubes
Housing
Malaria control
LLINs
Cost-effectiveness
Malaria
Vector-borne diseases
Mosquito vectors
Incidence
Lead sponsor: University of Notre Dame
Sponsor class: OTHER
Collaborators: name: Institut Pierre Richet
name: In2Care
First posted: 2023-02-21
Enrollment: 1870
Sex: ALL
Minimum age (years): 6
Maximum age (years): 10
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The goal of this clinical trial is to test whether In2Care EaveTubes (ETs) as a stand-alone tool can reduce malaria in an area where transmission is driven by insecticide-resistant Anopheles gambiae. Children who live in homes with ETs will be monitored for malaria infection and compared to children living in homes without ETs in Côte d'Ivoire where there is universal coverage of long lasting insecticide nets and pyrethroid resistance is high.

Detailed description: In2Care EaveTubes (ETs) are an inexpensive, new vector control product under World Health Organization (WHO) evaluation informed by mosquito ecology to efficiently target malaria vectors. By installing ETs in the walls of the house at eave level that funnel the natural airflow, mosquitoes are drawn in by the same heat and odor cues that typically attract them through the eaves. Once inside an ET, mosquitoes come into contact with insecticide-treated netting placed inside the ET.

The aim of this study is to test whether ETs as stand-alone tool have an effect on the epidemiology of malaria in villages where houses have been modified with the ET intervention. This prospective 2-arm cluster randomized control trial based on a WHO Vector Control Advisory Group approved protocol will include 17 intervention clusters and 17 control clusters. Both arms will have pyrethroid-treated bednets. Based on the population census, 55 households per cluster with eligible children will be randomly selected for recruitment into the active detection cohorts. In the intervention arm, we will enroll eligible children who reside in ET-treated houses. In the control arm, we will enroll children residing in villages without ET-treated houses. The intervention and control cohorts will be followed for 4 months for baseline covariate measurements and 24 months of a clinical follow up period. During case detection visits, blood samples will be taken from all febrile children and tested for malaria infection with rapid diagnostic tests. To assess the impact of the ET on mosquito density, entomological measurements will be conducted monthly in 20 clusters (10 ET, 10 Control) in 10 randomly selected households per cluster. To estimate the infectiousness of malaria vectors, sporozoite rates will be measured in subsets of the collected mosquito samples.

Eligibility criteria: Village Level Inclusion Criteria:

* ≥ 80% of Households (HHs) must be suitable for EaveTube(ET) installation.
* ≥70% of HHs willing to have ETs installed.
* No participation in the previous Screening + ETs cluster randomized control trial (cRCT).
* Received standard pyrethroid-only long lasting insecticide nets(LLINs) (Permanet 2.0).
* 100-300 HHs per village.
* ≥2 km apart from another village.

Village Level Exclusion Criteria:

* \< 80% of HHs suitable for ET installation.
* \<70% of HHs willing to have ETs installed.
* Villages being treated by indoor residual spray (IRS) and/or new generation bed net campaigns.
* Participation in previous Screening + ET cRCT.
* \<100 and \>300 households per village.
* \<2 km from another village.

Household Level Inclusion Criteria

* HHs must be suitable for ET installation.
* Provision of consent from heads of HH.

Household Level Exclusion Criteria

* HH not suitable for ET installation (e.g. houses with poor quality thatch roofing or very large eaves or wall gaps, houses in substantial disrepair, unfinished houses under construction, poorly constructed houses, ).
* No provision of consent from heads of HH.

Individual Level Inclusion Criteria

* Children aged ≥ 6 months to \< 8 years old at time of enrollment (so all participants are under 10 years old for the duration of clinical follow-up).
* Provision of written, informed consent by parents/care givers.
* Children must reside in villages enrolled in the study and in ETs-treated HHs.
* Hemoglobin at baseline of \>7 mg/dL.

Individual Level Exclusion Criteria

* Children aged \< 6 months or ≥ 8 years old at time of enrollment.
* No provision of written, informed consent by parents/care givers for child participation.
* Expected to be non-resident during a significant part of the transmission season.
* Hemoglobin at baseline of ≤7 mg/dL, have a known chronic disease, or who have signs of clinical decompensation.
* Participation in another clinical trial investigating a drug, vaccine, medical device or procedure.

Primary outcomes:
measure: Incidence rate of malaria infection
timeFrame: 24 months
Secondary outcomes:
measure: Clinical malaria incidence
timeFrame: 24 months
measure: Malaria parasitemia
timeFrame: 24 months
measure: Prevalence of moderate (defined as 7 - 9.9 g/dL hemoglobin) to severe anemia (<7 g/dL hemoglobin)
timeFrame: 24 months
measure: Mean numbers of female malaria mosquitoes (An. gambiae s.l., An funestus s.l.) captured in study houses
timeFrame: 24 months
measure: Malaria parasite sporozoite rate
timeFrame: 24 months
measure: Entomological Inoculation Rates
timeFrame: 24 months
Other outcomes:
measure: Cost-effectiveness of EaveTubes compared to the previously applies Screening + EaveTubes intervention, and compared to other vector control interventions such as LLINs and IRS.
timeFrame: 24 months
measure: User acceptance of EaveTubes
timeFrame: 24 months
Locations:
city: Bouaké
country: Côte D'Ivoire
facility: Institut Pierre Richet
Study officials:
affiliation: University of Notre Dame
name: John P Grieco, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Andriessen R, Snetselaar J, Suer RA, Osinga AJ, Deschietere J, Lyimo IN, Mnyone LL, Brooke BD, Ranson H, Knols BG, Farenhorst M. Electrostatic coating enhances bioavailability of insecticides and breaks pyrethroid resistance in mosquitoes. Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12081-6. doi: 10.1073/pnas.1510801112. Epub 2015 Aug 31.
citation: Barreaux AMG, Brou N, Koffi AA, N'Guessan R, Oumbouke WA, Tia IZ, Thomas MB. Semi-field studies to better understand the impact of eave tubes on mosquito mortality and behaviour. Malar J. 2018 Aug 22;17(1):306. doi: 10.1186/s12936-018-2457-4.
citation: Barreaux AMG, Oumbouke WA, Tia IZ, Brou N, Koffi AA, N'guessan R, Thomas MB. Semi-field evaluation of the cumulative effects of a "Lethal House Lure" on malaria mosquito mortality. Malar J. 2019 Aug 30;18(1):298. doi: 10.1186/s12936-019-2936-2.
citation: Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, Battle K, Moyes CL, Henry A, Eckhoff PA, Wenger EA, Briet O, Penny MA, Smith TA, Bennett A, Yukich J, Eisele TP, Griffin JT, Fergus CA, Lynch M, Lindgren F, Cohen JM, Murray CLJ, Smith DL, Hay SI, Cibulskis RE, Gething PW. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015 Oct 8;526(7572):207-211. doi: 10.1038/nature15535. Epub 2015 Sep 16.
citation: Bradley J, Rehman AM, Schwabe C, Vargas D, Monti F, Ela C, Riloha M, Kleinschmidt I. Reduced prevalence of malaria infection in children living in houses with window screening or closed eaves on Bioko Island, equatorial Guinea. PLoS One. 2013 Nov 13;8(11):e80626. doi: 10.1371/journal.pone.0080626. eCollection 2013.
citation: Carey JR, Muller HG, Wang JL, Papadopoulos NT, Diamantidis A, Koulousis NA. Graphical and demographic synopsis of the captive cohort method for estimating population age structure in the wild. Exp Gerontol. 2012 Oct;47(10):787-91. doi: 10.1016/j.exger.2012.06.012. Epub 2012 Jul 7.
citation: Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999 Apr;28(2):319-26. doi: 10.1093/ije/28.2.319.
citation: Kirby MJ, Ameh D, Bottomley C, Green C, Jawara M, Milligan PJ, Snell PC, Conway DJ, Lindsay SW. Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: a randomised controlled trial. Lancet. 2009 Sep 19;374(9694):998-1009. doi: 10.1016/S0140-6736(09)60871-0. Epub 2009 Sep 3.
citation: Koffi AA, Ahoua Alou LP, Adja MA, Chandre F, Pennetier C. Insecticide resistance status of Anopheles gambiae s.s population from M'Be: a WHOPES-labelled experimental hut station, 10 years after the political crisis in Cote d'Ivoire. Malar J. 2013 May 4;12:151. doi: 10.1186/1475-2875-12-151.
citation: Koffi AA, Ahoua Alou LP, Kabran JP, N'Guessan R, Pennetier C. Re-visiting insecticide resistance status in Anopheles gambiae from Cote d'Ivoire: a nation-wide informative survey. PLoS One. 2013 Dec 16;8(12):e82387. doi: 10.1371/journal.pone.0082387. eCollection 2013.
citation: Krajacich BJ, Slade JR, Mulligan RF, LaBrecque B, Alout H, Grubaugh ND, Meyers JI, Fakoli LS 3rd, Bolay FK, Brackney DE, Burton TA, Seaman JA, Diclaro JW 2nd, Dabire RK, Foy BD. Sampling host-seeking anthropophilic mosquito vectors in west Africa: comparisons of an active human-baited tent-trap against gold standard methods. Am J Trop Med Hyg. 2015 Feb;92(2):415-21. doi: 10.4269/ajtmh.14-0303. Epub 2014 Nov 24.
citation: Lengeler C. Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev. 2000;(2):CD000363. doi: 10.1002/14651858.CD000363.
citation: Lindsay SW, Snow RW. The trouble with eaves; house entry by vectors of malaria. Trans R Soc Trop Med Hyg. 1988;82(4):645-6. doi: 10.1016/0035-9203(88)90546-9. No abstract available.
citation: Lwetoijera DW, Kiware SS, Mageni ZD, Dongus S, Harris C, Devine GJ, Majambere S. A need for better housing to further reduce indoor malaria transmission in areas with high bed net coverage. Parasit Vectors. 2013 Mar 7;6:57. doi: 10.1186/1756-3305-6-57.
citation: Oumbouke WA, Tia IZ, Barreaux AMG, Koffi AA, Sternberg ED, Thomas MB, N'Guessan R. Screening and field performance of powder-formulated insecticides on eave tube inserts against pyrethroid resistant Anopheles gambiae s.l.: an investigation into 'actives' prior to a randomized controlled trial in Cote d'Ivoire. Malar J. 2018 Oct 22;17(1):374. doi: 10.1186/s12936-018-2517-9.
citation: Oumbouke WA, Pignatelli P, Barreaux AMG, Tia IZ, Koffi AA, Ahoua Alou LP, Sternberg ED, Thomas MB, Weetman D, N'Guessan R. Fine scale spatial investigation of multiple insecticide resistance and underlying target-site and metabolic mechanisms in Anopheles gambiae in central Cote d'Ivoire. Sci Rep. 2020 Sep 15;10(1):15066. doi: 10.1038/s41598-020-71933-8.
citation: Pinder M, Conteh L, Jeffries D, Jones C, Knudsen J, Kandeh B, Jawara M, Sicuri E, D'Alessandro U, Lindsay SW. The RooPfs study to assess whether improved housing provides additional protection against clinical malaria over current best practice in The Gambia: study protocol for a randomized controlled study and ancillary studies. Trials. 2016 Jun 3;17(1):275. doi: 10.1186/s13063-016-1400-7.
citation: Snetselaar J, Njiru BN, Gachie B, Owigo P, Andriessen R, Glunt K, Osinga AJ, Mutunga J, Farenhorst M, Knols BGJ. Eave tubes for malaria control in Africa: prototyping and evaluation against Anopheles gambiae s.s. and Anopheles arabiensis under semi-field conditions in western Kenya. Malar J. 2017 Jul 4;16(1):276. doi: 10.1186/s12936-017-1926-5.
citation: Sternberg ED, Ng'habi KR, Lyimo IN, Kessy ST, Farenhorst M, Thomas MB, Knols BG, Mnyone LL. Eave tubes for malaria control in Africa: initial development and semi-field evaluations in Tanzania. Malar J. 2016 Sep 1;15(1):447. doi: 10.1186/s12936-016-1499-8.
citation: Sternberg ED, Cook J, Alou LPA, Assi SB, Koffi AA, Doudou DT, Aoura CJ, Wolie RZ, Oumbouke WA, Worrall E, Kleinschmidt I, N'Guessan R, Thomas MB. Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial. Lancet. 2021 Feb 27;397(10276):805-815. doi: 10.1016/S0140-6736(21)00250-6.
citation: Tusting LS, Ippolito MM, Willey BA, Kleinschmidt I, Dorsey G, Gosling RD, Lindsay SW. The evidence for improving housing to reduce malaria: a systematic review and meta-analysis. Malar J. 2015 Jun 9;14:209. doi: 10.1186/s12936-015-0724-1.
citation: Tusting LS, Bottomley C, Gibson H, Kleinschmidt I, Tatem AJ, Lindsay SW, Gething PW. Housing Improvements and Malaria Risk in Sub-Saharan Africa: A Multi-Country Analysis of Survey Data. PLoS Med. 2017 Feb 21;14(2):e1002234. doi: 10.1371/journal.pmed.1002234. eCollection 2017 Feb.
citation: Wanzirah H, Tusting LS, Arinaitwe E, Katureebe A, Maxwell K, Rek J, Bottomley C, Staedke SG, Kamya M, Dorsey G, Lindsay SW. Mind the gap: house structure and the risk of malaria in Uganda. PLoS One. 2015 Jan 30;10(1):e0117396. doi: 10.1371/journal.pone.0117396. eCollection 2015.
citation: Sperling S, Cordel M, Gordon S, Knols BGJ, Rose A. Eave tubes for malaria control in Africa: Videographic observations of mosquito behaviour in Tanzania with a simple and rugged video surveillance system. Malariaworld J. 2017 Jul 1;8:9. eCollection 2017.
citation: Waite JL, Lynch PA, Thomas MB. Eave tubes for malaria control in Africa: a modelling assessment of potential impact on transmission. Malar J. 2016 Sep 2;15(1):449. doi: 10.1186/s12936-016-1505-1.